Munir, T, Howard, D orcid.org/0000-0003-3333-9783, McParland, L et al. (10 more authors) (2018) Obinutuzumab as consolidation after chemo-immunotherapy is highly effective in achieving MRD clearance from bone marrow and peripheral blood-Initial results of UK NCRI Phase II/III GALACTIC trial. In: British Journal of Haematology. 58th Annual Scientific Meeting of the British Society for Haematology, 16-18 Apr 2018, Liverpool, UK. Wiley , p. 79.
Metadata
Item Type: | Proceedings Paper |
---|---|
Authors/Creators: |
|
Keywords: | MRD |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) |
Funding Information: | Funder Grant number Cancer Research UK C18027/A13762 Roche Products Ltd MAWE1415R61 |
Depositing User: | Symplectic Publications |
Date Deposited: | 15 May 2018 09:48 |
Last Modified: | 15 May 2018 09:48 |
Status: | Published |
Publisher: | Wiley |
Identification Number: | 10.1111/bjh.15226 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:130731 |